WallStSmart
ICCM

Icecure Medical

NASDAQ: ICCM · HEALTHCARE · MEDICAL DEVICES

$0.27
-1.28% today

Updated 2026-04-29

Market cap
$23.07M
P/E ratio
P/S ratio
6.83x
EPS (TTM)
$-0.24
Dividend yield
52W range
$0 – $1
Volume
0.6M

Icecure Medical (ICCM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+35.9%
Last 4 quarters
Revenue YoY growth
+46.2%
Most recent quarter
EPS YoY growth
+25.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-23.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-36.3%
2026-03-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.06-20.0%$0.59$0.37-36.3%
2025-11-19$-0.06-11.3%$0.72$0.65-10.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.05$-0.06-20.0%$1.28M+46.2%
2025-09-30$-0.05$-0.06-11.3%$850000.00+28.4%
2025-06-30$-0.06$-0.06+0.0%$525000.00-48.1%
2025-03-31$-0.08$0.06+175.0%$725000.00-1.5%
2024-12-31$-0.08$-0.08+0.0%$875000.00-30.3%
2024-09-30$-0.07$-0.08-10.2%$662000.00+102.4%
2024-06-30$-0.07$-0.06+14.3%$1.01M+7.9%
2024-03-31$-0.08$-0.08+0.0%$736350.00+3.7%
2023-12-31$-0.08$-0.06+21.8%$1.25M
2023-09-30$-0.09$-0.09+0.0%$327000.00
2023-06-30$-0.09$-0.08+11.1%$937000.00
2023-03-31$-0.09$-0.08+11.1%$710000.00

Frequently asked questions

Has Icecure Medical beaten earnings estimates?
Icecure Medical has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +35.9% over the last 4 quarters.
How does ICCM stock react to earnings?
ICCM stock has moved an average of -23.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Icecure Medical's revenue growth rate?
Icecure Medical reported year-over-year revenue growth of +46.2% in its most recent quarter, with EPS growing +25.0% year-over-year.